Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4202214> ?p ?o }
Showing triples 1 to 10 of
10
with 100 triples per page.
- Q4202214 subject Q8548696.
- Q4202214 abstract "Influvac is a sub-unit vaccine produced and marketed by Abbott Laboratories. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B Virus) that are selected and distributed by the World Health Organization, on the basis of their latest recommendations.In February 2010, Abbott acquired the vaccines sub-unit from Solvay Pharmaceuticals included in its $6.2 billion purchase and the sub-unit influenza vaccine - Influvac has been commercially available on the market since the early nineteen-eighties. With the acquisition of Solvay, Abbott retained access to the Eastern European, Middle Eastern & Latin American markets. Approximately $850 million of sales revenue from vaccines was reported by Solvay Pharmaceuticals in 2009.".
- Q4202214 wikiPageWikiLink Q1089532.
- Q4202214 wikiPageWikiLink Q161393.
- Q4202214 wikiPageWikiLink Q306764.
- Q4202214 wikiPageWikiLink Q706184.
- Q4202214 wikiPageWikiLink Q7817.
- Q4202214 wikiPageWikiLink Q8548696.
- Q4202214 comment "Influvac is a sub-unit vaccine produced and marketed by Abbott Laboratories.".
- Q4202214 label "Influvac".